In the TMA cohort, Kaplan-Meier analysis revealed a significant correlation between low BCL6B staining and a poor overall 5-year survival in all HCC patients (p = 0.026, log rank test; Figure 2A). This evidence concerns the gene BCL6B and hepatocellular carcinoma.